doi: http://dx.doi.org/10.5195/ijms.2024.2449
Volume 12, Number 1: 43-52
Received 10 11 2023; Rev-request 06 12 2023; Rev-recd 12 12 2023; Accepted 22 03 2024
ABSTRACT
Background:Disorders of Gut-Brain Interaction (DGBI) affect 40% of the general population and are associated with substantial health impairment. Medical students reportedly have among the highest rates of DGBI, although data is mainly from Asia and Africa. We addressed this issue within a UK-based university.
Methods:An online survey was completed by 378 of 1621 medical students. Demographics, medical history, and gastrointestinal symptoms were collected, the latter using a modified Rome IV questionnaire to determine the presence of DGBI symptoms over the last 3 months. Additional validated questionnaires screened for somatization, psychological distress, eating disorders, quality of life, and burnout.
Results:DGBI were present in 76% (n=289/378), of which two-of-three had multiple affected sites. The most frequent DGBI were gastroduodenal (57%), followed by bowel (49%), esophageal (29%), and anorectal (26%) disorders. Approximately 50% of students with DGBI experienced painful gastrointestinal symptoms at least one day/week. Students with DGBI, compared to those without, had significantly higher anxiety and depression scores, increased somatic symptom reporting, reduced mental and physical quality of life, poorer eating habits, and more frequent medication use (p-values, all<0.05). They were also at significantly higher risk of burnout, through study exhaustion and disengagement. The greatest health impairment was seen in those with multiple, painful, DGBI. Only 23% and 5% of students with DGBI had consulted a primary care provider and gastroenterologist, respectively.
Conclusion:Medical students commonly experience DGBI and associated health burden, yet infrequently seek help. Greater awareness may lead to increased support, improved health, and better study engagement.
Disorders of Gut Brain Interaction (DGBI), formerly known as functional gastrointestinal disorders, are defined as chronic gastrointestinal symptoms in the absence of organic gastrointestinal disease to explain the symptoms (i.e. no evidence of infection, inflammatory diseases, ulcers, or cancer).1 The pathophysiology of DGBI is not fully known but can be best understood based on the biopsychosocial model of illness, and relates to any combination of visceral hypersensitivity, motility disturbances, alterations in mucosal and immune function, gut microbiota, and central nervous system processing.1 Whilst irritable bowel syndrome (IBS) and functional dyspepsia are the most commonly recognized DGBI, there are a total of 22 DGBI which can arise from any of the following six anatomical regions within the gastrointestinal (GI) tract; the esophagus, gastroduodenum, bowel, biliary, centrally mediated, and anorectum.
A recent global epidemiological study reported that over 40% of adults fulfill symptom-based criteria for a DGBI and incur considerable physical and mental health impairment, high healthcare utilization, decreased work productivity, and reduced quality of life.2 Furthermore, one-in-three individuals with DGBI in the general population have multiple anatomical regions affected, which is associated with even greater health impairment.3 Finally, eating disorders are common in patients with DGBI attending tertiary care medical centers, although their prevalence among people with DGBI within the community is unknown.4
There is data to suggest that medical students have amongst the highest rates of DGBI, with prevalence rates exceeding those reported within the general population (Supplementary Table). This, in part, may be explained by medical students across the globe experiencing high levels of stress, anxiety, depression, and burnout,5,6 which could lead to gut symptoms through the bi-directional communication between the brain-gut axis. As shown in Supplementary Table the prevalence of IBS in medical students ranges from 4.8-61.7% (compared to 3.8% in the global adult population),2 while the prevalence of functional dyspepsia ranges from 0.66-34.8% (compared to 7.2% globally).2 However, most of this literature comes from Asia and Africa, and predominantly focuses on IBS and functional dyspepsia as opposed to all other DGBI, and with limited information on the general overall burden of DGBI amongst this cohort. As such, the present study aimed to determine the prevalence and burden of DGBI amongst medical students in the United Kingdom (UK).
Following internal university assessment and ethical approval (ref 044371), this cross-sectional study was conducted at the University of Sheffield medical school during the academic year 2022-2023. Individuals currently enrolled within the medical school were invited in November 2022 to complete an online survey (using Google forms platform) regarding general physical and mental health. Completing and submitting the online survey was deemed as informed consent. The study was anonymous as no personal identification details were recorded (i.e., name, date of birth, university registration number, e-mail address). No financial incentives were provided.
The following questionnaires were completed:
Categorical variables were summarized using descriptive statistics and compared using chi-squared test, or Fisher's exact test, as necessary. In addition, odds ratios (OR) with 95% confidence intervals (CI) were calculated for some categorical variables between those with and without symptoms compatible with DGBI, and separately between those with painful and non-painful DGBIs. Continuous variables were summarized using mean and standard deviation, with between-group comparison obtained using an independent samples t-test. Finally, bivariate correlation was used to examine the strength and direction of the relationship between continuous variables.
Statistical analysis was conducted using IBM SPSS version 28 (SPSS Inc, Chicago, Illinois, United States). The level of significant was set at a p-value of <0.05.
The online survey was disseminated to 1621 medical students of whom 378 completed, giving a response rate of 23%. The mean age of respondents was 21 years (SD 2.5), with 73% being female, and 70% of white ethnicity.
The prevalence of having at least one DGBI over the last 3 months amongst medical student respondents was 76% (n=289), with almost half affected by DGBI across multiple anatomical regions (see Figure 1). Prevalence of all individual DGBIs studied are displayed in Table 1. Amongst the entire cohort, the most frequently met diagnostic criteria for DGBI were gastroduodenal (n=214, 57%), followed by bowel (n=184, 49%), esophageal (n=110, 29%), and anorectal (n=98, 26%) disorders. IBS and functional dyspepsia affected 17% and 28% of the cohort respectively, while other common DGBI included functional nausea and vomiting (37%), belching disorders (26%), anorectal disorders (25%), functional bloating (23%), functional chest pain (16%), globus (15%), and functional dysphagia (11%).
Figure 1The Number of Anatomical Regions Affected by Disorders of Gut Brain Interaction (DGBI) Amongst 378 Medical Students.
Prevalence of Specific Disorders of Gut Brain Interaction (DGBI) Diagnoses Amongst Medical Students (n=378).
Anatomical Region | Disorder of Gut-Brain Interaction | n (%) |
---|---|---|
Esophageal (n=110, 29%) | Globus | 57 (15%) |
Functional chest pain | 61 (16%) | |
Functional heartburn | 35 (9%) | |
Functional dysphagia | 40 (11%) | |
Gastroduodenal (n=214, 57%) | Functional dyspepsia (FD) | 106 (28%) |
Post prandial distress syndrome (PDS) | 78 (21%) | |
Epigastric pain syndrome (EPS) | 45 (12%) | |
Functional nausea and vomiting disorders | 141 (37%) | |
Rumination syndrome | 26 (7%) | |
Belching disorders | 98 (26%) | |
Bowel (n=184, 49%) | Irritable bowel syndrome (IBS) | 63 (17%) |
Functional constipation | 16 (4%) | |
Functional diarrhea | 14 (4%) | |
Unspecified bowel disorder | 3 (1%) | |
Functional bloating | 88 (23%) | |
Anorectal (n=98, 26%) | Fecal incontinence | 12 (3%) |
Functional anorectal disorders | 93 (25%) |
Table 2 compares the DGBI cohort against those with no-DGBI. There was no difference in mean age or year of study, including when stratified into pre-clinical and clinical students. However, medical students with DGBI were over twice as likely to be female than those without (77% vs. 61%, OR 2.1, 95% CI 1.3-3.6). There was no difference between the two cohorts regarding self-reported smoking status, alcohol use or illicit drug use. However, a high number of individuals reported consuming alcohol in both groups (over 70%), although no quantification regarding frequency or amount of alcohol was obtained.
Table 2.Characteristics of Medical Students with and without Rome IV Disorders of Gut Brain Interaction (DGBI).
Study Variables | Symptoms not compatible with a Rome IV DGBI (n=89) | Symptoms compatible with Rome IV DGBI (n=289) | p-value | Odds ratio (95% CI) |
---|---|---|---|---|
Demographics | ||||
Mean age in years (SD) | 20.6 (2.5) | 20.8 (2.5) | 0.69 | -- |
Mean year of study (SD) | 2.6 (1.5) | 2.6 (1.5) | 0.93 | -- |
Pre-clinical | 47 (53%) | 167 (58%) | 0.41 | 1.2 (0.8–2.0) |
Female | 54 (61%) | 222 (77%) | 0.003 | 2.1 (1.3–3.6) |
Heterosexual | 77 (87%) | 201 (70%) | 0.002 | 0.4 (0.2–0.7) |
White | 53 (60%) | 212 (73%) | 0.013 | 1.9 (1.1–3.1) |
Drink Alcohol | 66 (74%) | 239 (83%) | 0.074 | 1.7 (0.9–2.9) |
Smoke Tobacco | 5 (6%) | 14 (5%) | 0.78 | 0.9 (0.3–2.4) |
Use Cannabis/Marijuana | 5 (6%) | 17 (6%) | 0.93 | 1.1 (0.4–2.9) |
Use other illicit drugs | 2 (2%) | 16 (6%) | 0.26 | 2.5 (0.6–11.3) |
Past medical history | ||||
Anxiety | 11 (12%) | 81 (28%) | 0.003 | 2.8 (1.4–5.5) |
Depression | 9 (10%) | 65 (23%) | 0.01 | 2.6 (1.2–5.4) |
Eating disorder | 3 (3%) | 18 (6%) | 0.43 | 1.9 (0.5–6.6) |
COVID-19 infection | 45 (51%) | 197 (68%) | 0.002 | 2.1 (1.3–3.4) |
Any abdominal surgery | 7 (8%) | 20 (7%) | 0.76 | 0.9 (0.4–2.1) |
Medication use | ||||
Any GI medication | 1 (1%) | 42 (15%) | <0.001 | 15.0 (2.0–110.3) |
Constipation | 0 (0%) | 9 (3%) | 0.12 | 0.8 (0.7–0.8) |
Diarrhea | 0 (0%) | 9 (3%) | 0.12 | 0.8 (0.7–0.8) |
Nausea | 0 (0%) | 7 (2%) | 0.21 | 0.8 (0.7–0.8) |
Antispasmodics | 0 (0%) | 9 (3%) | 0.12 | 0.8 (0.7–0.8) |
Stomach acid | 1 (1%) | 24 (8%) | 0.02 | 8.0 (1.1–59.8) |
Non-opioid painkillers | 8 (9%) | 87 (30%) | <0.001 | 4.4 (2.0–9.4) |
Opioid painkillers | 0 (0%) | 3 (1%) | 1 | 0.8 (0.7–0.8) |
Anxiolytics/antidepressants | 6 (7%) | 41 (14%) | 0.06 | 2.3 (0.9–5.6) |
Healthcare utilization | ||||
Primary care | 8 (9%) | 66 (23%) | 0.004 | 3.0 (1.4–6.5) |
Gastroenterologist | 5 (6%) | 15 (5%) | 0.79 | 0.9 (0.3–2.6) |
Mental health | 19 (21%) | 98 (34%) | 0.03 | 1.9 (1.1–3.3) |
Burden | ||||
Eating Disorder (SCOFF ≥2) | 12 (14%) | 87 (30%) | 0.002 | 2.8 (1.4–5.3) |
HADS-Anxiety ≥ 11 | 14 (16%) | 101 (35%) | <0.001 | 2.9 (1.5–5.3) |
HADS-Depression ≥ 11 | 3 (3%) | 21 (7%) | 0.19 | 2.2 (0.7–7.7) |
Burden, Mean (SD) | ||||
PHQ-12 score | 3.5 (2.9) | 6.3 (3.6) | <0.001 | -- |
Number of PHQ-12 sites | 2.9 (2.1) | 4.9 (2.5) | <0.001 | -- |
SF-8 PCS QOL | 83.1 (1.45) | 73.8 (18.5) | <0.001 | -- |
SF-8 MCS QOL | 72.1 (21.1) | 61.9 (20.0) | <0.001 | -- |
HADS-Anxiety score | 6.5 (4.0) | 9.0 (4.3) | <0.001 | -- |
HADS-Depression score | 2.9 (3.1) | 4.2 (3.5) | <0.002 | -- |
OLBI-Disengagement score | 17.0 (4.0) | 18.2 (4.0) | 0.01 | -- |
OLBI-Exhaustion score | 19.3 (4.1) | 21.5 (4.1) | <0.001 | -- |
Medical students with DGBI were significantly more likely than those without DGBI to have previously been diagnosed with anxiety (28% vs. 12%, p=0.003) and depression (23% vs. 10%, p=0.01). They were also significantly more likely to use at least one type of GI medication (15% vs. 1%, p<0.001), and non-opioid painkillers (30% vs. 9%, p<0.001), compared to those without DGBI. Whilst those with DGBI were more likely to have sought healthcare at university for their gastrointestinal symptoms, this was still relatively low, with only 23% consulting a primary care provider, 33% a mental health specialist, and 5% a gastroenterologist.
In accordance with the SCOFF questionnaire, medical students with DGBI were almost three times more likely than those without DGBI to have an eating disorder (30% vs. 14%, p=0.002). They also had significantly worse mean somatization scores (6.3 vs. 3.5, p<0.001), more somatic sites affected (4.9 vs. 2.9, p<0.001), and worse mean anxiety (9.0 vs. 6.5, p<0.001) and depression (4.2 vs. 2.9, p<0.002) scores. Finally, those with DGBI reported significantly worse quality of life and higher levels of burnout, regarding both study disengagement and exhaustion, than those without DGBI.
Amongst those with at least one DGBI, almost 2-in-3 (63%) of individuals had multiple affected anatomical sites, and 12% had all 4 anatomical regions affected. The possible overlaps between anatomical regions are displayed in Figure 2, whilst Table 3 demonstrates the correlation between increasing number of DGBIs and worsening quality of life (i.e., negative correlation), and greater burnout, somatization, anxiety, and depression scores (i.e., positive correlation).
Figure 2Venn Diagram Showing the Overlap Between Anatomical Regions in Those Medical Students with Disorders of Gut Brain Interaction (DGBI) (n=289).
Relationship Between Psychological Distress and Number of Anatomical Sites Affected by DGBIs.
Variable | Number of anatomical sites affected by DGBIs | |
---|---|---|
Correlation | p value | |
SF-8 MCS QOL | −0.397 | <0.001 |
SF-8 PCS QOL | −0.389 | <0.001 |
OLBI-Disengagement score | 0.245 | <0.001 |
OLBI-Exhaustion score | 0.314 | <0.001 |
PHQ-12 somatic score | 0.528 | <0.001 |
Number of PHQ-12 sites | 0.526 | <0.001 |
HADS-Anxiety score | 0.461 | <0.001 |
HADS-Depression score | 0.293 | <0.001 |
Table 4 compares the painful DGBI cohort against those with non-painful DGBI. We defined painful DGBI as having pain at least one day per week from any anatomical GI region; this case definition was met by 51% (n=147/289) of those with DGBI. Amongst those with painful DGBI, 58% (n=85) had one painful anatomical site, 27% (n=39) had two, 14% (n=20) had three and 2% (n=3) had painful DGBI across all 4 anatomical sites.
Table 4.Comparison Between Medical Students with and without Painful Disorders of Gut Brain Interaction (DGBI).
Cohort with DGBI (n=289) | Non-painful DGBIs (n=142) | Painful DGBIs (n=147) | p-value | Odds ratio(95% CI) | |
---|---|---|---|---|---|
Demographics | |||||
Mean age in years (SD) | 20.5 (2.6) | 21.0 (2.4) | 0.06 | -- | |
Mean year of study (SD) | 2.4 (1.6) | 2.8 (1.4) | 0.05 | -- | |
Pre-clinical | 87 (61%) | 80 (54%) | 0.24 | 0.8 (0.5–1.2) | |
Female | 99 (70%) | 123 (84%) | 0.005 | 2.2 (1.3–3.9) | |
Heterosexual | 105 (74%) | 96 (65%) | 0.11 | 0.7 (0.4–1.1) | |
White | 96 (68%) | 116 (79%) | 0.03 | 2.8 (1.1–3.0) | |
Past medical history | |||||
Anxiety | 23 (16%) | 58 (40%) | <0.001 | 3.4 (1.9–5.9) | |
Depression | 15 (11%) | 50 (34%) | <0.001 | 4.4 (2.3–8.2) | |
Eating disorder | 3 (2%) | 15 (10%) | 0.004 | 5.2 (1.5–18.6) | |
COVID-19 Infection | 95 (67%) | 102 (69%) | 0.65 | 1.1 (0.7–1.8) | |
Any abdominal surgery | 9 (6%) | 11 (8%) | 0.70 | 1.2 (0.5–3.0) | |
Medication use | |||||
Any I medication | 12 (9%) | 30 (20%) | 0.004 | 2.8 (1.4–5.7) | |
Constipation | 4 (3%) | 5 (3%) | 1.00 | 1.2 (0.3–4.6) | |
Diarrhea | 3 (2%) | 6 (4%) | 0.50 | 2.0 (0.5–8.0) | |
Nausea | 2 (1%) | 5 (3%) | 0.45 | 2.5 (0.5–12.9) | |
Antispasmodics | 1 (1%) | 8 (5%) | 0.04 | 8.1 (1.0–65.7) | |
Stomach acid | 6 (4%) | 18 (12%) | 0.01 | 3.2 (1.2–8.2) | |
Non-opioid painkillers | 34 (24%) | 53 (36%) | 0.03 | 1.8 (1.1–3.0) | |
Opioid painkillers | 1 (1%) | 2 (1%) | 1.00 | 1.9 (0.2–21.7) | |
Anxiolytic/antidepressants | 10 (7%) | 31 (21%) | <0.001 | 3.5 (1.7–7.5) | |
Healthcare utilization at university | |||||
Primary care | 17 (12%) | 49 (33%) | <0.001 | 3.7 (2.0–6.8) | |
Gastroenterologist | 4 (3%) | 11 (8%) | 0.07 | 2.8 (0.9–9.0) | |
Mental health | 30 (20%) | 68 (46%) | <0.001 | 3.2 (1.9–5.4) | |
Burden of DGBIs | |||||
Eating Disorder (SCOFF ≥2) | 33 (23%) | 54 (37%) | 0.01 | 1.9 (1.1–3.2) | |
HADS-Anxiety ≥ 11 | 31 (22%) | 70 (48%) | <0.001 | 3.3 (1.9–5.4) | |
HADS-Depression ≥ 11 | 6 (4%) | 15 (10%) | 0.05 | 2.6 (1.0–6.8) | |
Burden of DGBIs: | Number of painful DGBI sites | ||||
Mean (SD) | Correlation | P value | |||
PHQ-12 somatic score | 4.9 (2.9) | 7.5 (3.8) | <0.001 | 0.446 | <0.001 |
Number of PHQ-12 sites | 4.0 (2.2) | 5.8 (2.5) | <0.001 | 0.432 | <0.001 |
SF-8 PCS QOL | 79.8 (14.6) | 68.1 (20.0) | <0.001 | −0.322 | <0.001 |
SF-8 MCS QOL | 69.1 (17.6) | 55.0 (19.8) | <0.001 | −0.348 | <0.001 |
HADS-Anxiety score | 7.7 (3.9) | 10.3 (4.3) | <0.001 | 0.414 | <0.001 |
HADS-Depression score | 3.6 (3.1) | 4.8 (3.7) | 0.003 | 0.245 | <0.001 |
OLBI-Disengagement score | 17.6 (3.7) | 18.8 (4.1) | 0.01 | 0.184 | 0.002 |
OLBI-Exhaustion score | 21.0 (4.1) | 22.1 (4.0) | 0.02 | 0.192 | <0.001 |
Individuals with painful DGBIs, and in particular those with multiple painful sites, were significantly more likely to have higher levels of anxiety, depression, somatization, eating disorders, burnout, and reduced quality of life. They also reported significantly higher use of anti-spasmodic medications, acid suppressive drugs and non-opioid pain killers. While those with painful DGBI were significantly more likely to seek a healthcare provider, this was still relatively infrequent with 33% having seen a primary care provider, 46% a mental health specialist, and only 8% having seen a gastroenterologist.
To our knowledge, this is the first study to examine the prevalence and burden of DGBI amongst UK medical students. We found that 76% of UK medical students who completed this anonymous online survey had symptoms compatible with a Rome IV DGBI, which is much higher than the reported prevalence of 37% amongst the UK general adult population.2 Furthermore, almost two-thirds of medical students with DGBI had multiple affected anatomical sites, and over half experienced painful gastrointestinal symptoms at least once per week. The presence of DGBI was associated with psychological distress, somatic symptom reporting, eating disorders, burnout, and reduced quality of life, yet medical students infrequently seek help for their symptoms, even when painful.
The general health burden of DGBI as seen in medical students aligns with that reported for the general population, although it appears to be of a greater severity. For example, over 50% of medical students with DGBI experience frequent painful symptoms - which in itself correlated with increased physical and mental distress – in comparison to 26% of UK adults with DGBI having painful DGBI.14 Many of the risk factors for painful DGBI (e.g. female sex, gastroenteritis, abuse, stress, poor sleep, obesity, psychological disorders, and somatic symptoms) were explored and apparent within our medical student cohort.15 Protective factors against painful DGBI in adults include social support and optimism,15 yet rates of healthcare utilization or support for DGBI symptoms were low amongst medical students. For instance, less than a quarter of those with DGBI, and only a third of those with painful DGBI, had consulted a primary care provider regarding their GI symptoms. This supports previous findings that medical students have low rates of healthcare consultation for DGBI symptoms16–18 although reasons for this remain unclear. Possible fear of repercussions regarding training progression and general stigma surrounding ill-health can prevent medical students from seeking help for their physical and mental health.19,20 DGBI are also under-taught within medical education which might lead to a lack of awareness of these disorders amongst medical students.21
A high proportion of medical students with DGBI had associated psychological distress, burnout (i.e., study exhaustion and disengagement) and eating disorders. These factors have been reported in DGBI within the general population, but are arguably more prevalent within medical students given the extensive demands placed upon them from a relatively young age.5,6 Medicine has traditionally been considered as a highly demanding and stressful course, with a competitive admission process followed by frequent and rigorous examinations over a 5 to 6 year period.5,6 Moreover, students face additional pressures to conduct research, publish in scientific journals, teach, build management and leadership skills and win prizes in order to choose the specialty of their choice. Additional stressors over this time-period include relationships, financial difficulties and housing issues, all of which have been heightened by the COVID-19 pandemic.5,6 Hence, it is not surprising that high levels of psychiatric illness, burnout and substance use are being reported by medical students across the globe.5,6 A recent study found that 29% of medical students respondents were given a mental health diagnosis whilst at medical school, and 82% could be classified as 'disengaged' and 85% 'exhausted' using the Oldenburg Burnout Scale.22 In England and Wales, over 80% of medical students have high levels of burnout,22,23 whilst a global systematic review and meta-analysis reported that medical students have a higher burden of burnout than age-matched peers.24 An association between burnout and IBS has been reported,25,26 which our study builds upon by highlighting the relationship between burnout and overall DGBI amongst medical students. Similarly, there is association between eating disorders and DGBI,4 and a global systematic review found medical students have higher rates of eating disorders than the general adult population.27 In summary, the combination of DGBI and its associated health impairment may lead to reduced academic performance, increased dropout, and potential long-term consequences for patient safety. Medical schools should therefore become familiar with the high prevalence and burden of DGBI, openly raise awareness of these conditions, and sign-post students to seek help via appropriate channels. Future research studies should investigate interventions suggested for DGBI but specifically within medical students (e.g., diet, lifestyle, exercise, antispasmodics, psychological support etc.). Hopefully, these measures will not just positively impact upon medical students as they progress to doctors, but also for patients and the healthcare system.
There are limitations to this study. First, the cross-sectional study design identifying an association between DGBI and other co-morbidities does not infer causality. Second, it was conducted at only one university, and may not be representative of medical students at other UK institutions. Moving forward, it raises interest to conduct further studies of DGBI in medical students elsewhere, but also among junior doctors in whom a high prevalence of stress and burnout, leading to career disengagement and reduced patient quality of care, is increasingly being recognised.28 Third, there was no comparative control group, either from another course within the university or the general population. However, the prevalence of DGBI within medical students reported in this UK study, and that from India, far exceed those reported within their respective general populations.2,29 The study from India also reported DGBI to be significantly more common in medical students than its humanities students.29 Fourth, the low response rate of 23% (n=378/1621) may mean that the reported prevalence of DGBI as 76% (n=289/378) is not reflective of the prevalence of DGBI amongst the entire cohort of medical students at the university. However, we aimed to reduce potential selection bias by promoting the study as an evaluation of physical and mental health, as opposed to specifically mentioning gastrointestinal symptoms. Nevertheless, the results could be extrapolated to calculate the minimum possible prevalence of DGBI for the entire population of medical students at the university, i.e., if all the non-responders were presumed to lack any symptoms compatible with DGBI, the minimum prevalence of DGBI in this cohort would be 18% (n=289/1621). This equates to almost 1-in-5 medical students and still suggests a high prevalence. Fifth, the predominance responders to the survey were female (73%), although the female to male ratio in the medical school is almost 1:1, again adding to potential selection bias. Sixth, we did not use the Rome IV diagnostic questionnaire in its entirety, as it encompasses 86 questions with a complex scoring algorithm, but rather selected 17 pertinent questions that captured the spectrum of gastrointestinal symptoms followed by using clinically relevant frequency cut-offs to determine the presence of DGBI and painful DGBI. Further, the Rome diagnostic criteria require symptoms to be active over the last 3 months but to have started at least 6 months prior. The latter we did not enquire for and might therefore have over-estimated the prevalence of Rome IV DGBI, although the frequent presence of symptoms, particularly those that are painful, is nevertheless of concern. Seventh, the use of an anonymous study questionnaire meant that results could not be corroborated through clinical notes, nor could investigations be done. As such, some of the reported symptoms may have been due to underlying organic disease, although this is unlikely in individuals of a relatively young age reporting chronic symptoms. Finally, the most common DGBI in this study was functional nausea and vomiting disorders, with a prevalence of 37%, which is much higher than the global prevalence of around 1.0% in the 18-39 age group.2 This marked difference may be due to a high rate of alcohol use in the study population, with 78% of medical students drinking alcohol, although we did not quantify individuals' drinking habits. Previous research suggests that UK medical students have high rates of alcohol misuse.30 Therefore, for some individuals in this study, the symptoms of functional nausea and vomiting disorders may have instead been caused by alcohol consumption.
In conclusion, DGBI are common and burdensome among UK medical students, yet they infrequently seek help for their symptoms, even when painful. Increased awareness of DGBI amongst medical students may lead to improved support, health status, and study engagement.
Disorders of gut-brain interaction (DGBI) are chronic gastrointestinal symptoms that occur in the absence of organic disease. In this UK based study, the prevalence of symptoms compatible with DGBI amongst medical students at Sheffield University was 76% of whom two-of-three had multiple affected anatomical sites. Approximately 50% of medical students reported experiencing pain from a GI region at least once per week. The presence of DGBI (in particular, multiple painful DGBI) was associated with anxiety, depression, somatization, eating disorders, reduced quality of life, and burnout through study disengagement and exhaustion. Medical students with DGBI had low healthcare utilization relative to their symptom burden. Our findings will help increase awareness of DGBI amongst medical students and may lead to improved support, health status, and study engagement.
None.
The Authors have no funding, financial relationships or conflicts of interest to disclose.
Conceptualization: LCB, IA. Data Curation: LCB, IA. Formal Analysis: LCB, IA. Investigation: LCB, IA. Methodology: LCB, IA. Supervision: IA. Writing - Original Draft: LCB, IA. Writing - Review Editing: LCB, IA.
Cite as Brown LC, Aziz I. Prevalence and Burden of Disorders of Gut-Brain Interaction Among UK Medical Students. Int J Med Stud. 2024 Jan-Mar;12(1):43-52.
1. Drossman DA, Hasler WL. Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257–61.
2. Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Resultsof Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3.
3. Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: A cross-sectional general populationstudy in threecountries. Am J Gastroenterol. 2018;113(1):86–96.
4. Staller K, Abber SR, Burton Murray H. The intersection between eating disorders and gastrointestinal disorders: a narrative review and practical guide. Lancet Gastroentero lHepatol. 2023;8(6):565–78.
5. Molodynski A, Lewis T, Kadhum M, Farrell SM, LemtiriChelieh M, Falcão De Almeida T, et al. Cultural variations in wellbeing, burnout and substance use amongst medical students in twelve countries. Int Rev Psychiatry. 2021;33(1-2):37–42.
6. Kadhum M, Ayinde OO, Wilkes C, Chumakov E, Dahanayake D, Ashrafi A, et al. Wellbeing, burnout and substance use amongst medical students: A summary of results from nine countries. Int J Soc Psychiatry. 2022;68(6):1218–22.
7. Palsson OS, Whitehead WE, Van Tilburg MAL, Chang L, Chey W, Crowell MD, et al. Development and Validation of the Rome IV Diagnostic Questionnaire for Adults. Gastroenterology. 2016;150(6):1481–91.
8. Morgan JF, Reid F, Lacey JH. The SCOFF Questionnaire: Assessmentof a New Screening Tool for Eating Disorders. BMJ. 1999;319(7223):1467–8.
9. Hill LS, Reid F, Morgan JF, Lacey JH. SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord. 2010;43(4):344–51.
10. Spiller RC, Humes DJ, Campbell E, Hastings M, Neal KR, Dukes GE, et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor ofsymptomseverity and consultingbehaviour in patientswith irritable bowelsyndrome and symptomatic diverticular disease. Aliment Pharmacol Ther. 2010;32(6):811–20.
11. Zigmond AS, Snaith RP. The Hospital Anxiety and DepressionScale. Acta Psychiatr Scand. 1983;67(6):361–70.
12. Ware JE, Kosinski M, Dewey JE, Gandek B. How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey. Lincoln, RI: Quality Metric Incorporated. 2001;15(10):5.
13. Demerouti E, Bakker AB. The Oldenburg Burnout Inventory: A good alternative to measure burnout and engagement. Handbook of stress and burnout in health care. 2008;65(7):1–25.
14. Luo Y, Camey SA, Bangdiwala SI, Palsson OS, Sperber AD, Keefer LA. Global patterns of prescription pain medication usage in disorders of gut–braininteractions. Neurogastroenterol Motil. 2023;35(1):e14457.
15. Zia JK, Lenhart A, Yang PL, Heitkemper MM, Baker J, Keefer L, et al. Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review. Gastroenterology. 2022;163(4):995–1023.e3.
16. Tan Y-M, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: A survey among medical students. J Gastroenterol Hepatol. 2003;18(12):1412–6.
17. Gallas S, Knaz H, Methnani J, Maatallah Kanzali M, Koukane A, Bedoui MH, et al. Prevalence and risk factors of functional gastrointestinal disorders in early period medical students: a pilot study in Tunisia. Libyan J Med. 2022;17(1).
18. Jafri W, Yakoob J, Jafri N, Islam M, Ali QM. Frequency of irritable bowel syndrome in college students. J Ayub Med Coll Abbottabad. 2005;17(4):9.
19. Shahaf-Oren B, Madan I, Henderson C. “A lot of medical students, their biggest fear is failing at being seen to be a functional human”: disclosure and help-seeking decisions by medical students with health problems. BMC Med Educ. 2021;21(1):1–599.
20. Menon V, Sarkar S, Kumar S. A cross-sectional analysis of barriers to health-care seeking among medical students across training period. J Ment Health Hum Be. 2017;22(2):97–103.
21. Simons J, Shajee U, Palsson O, Simren M, Sperber AD, Törnblom H, et al. Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education. United European Gastroenterol J. 2022;10(7):736–44.
22. Farrell SM, Kadhum M, Lewis T, Singh G, Penzenstadler L, Molodynski A. Wellbeing and burnout amongst medical students in England. Int Rev Psychiatry. 2019;31(7-8):579–83.
23. Farrell SM, Molodynski A, Cohen D, Grant AJ, Rees S, Wullshleger A, et al. Wellbeing and burnout among medical students in Wales. Int Rev Psychiatry. 2019;31(7-8):613–8.
24. Erschens R, Keifenheim KE, Herrmann-Werner A, Loda T, Schwille-Kiuntke J, Bugaj TJ, et al. Professional burnout among medical students: Systematic literature review and meta-analysis. Med Teach. 2019;41(2):172–83.
25. Hod K, Melamed S, Dekel R, Maharshak N, Sperber AD. Burnout, butnotjobstrain, isassociatedwith irritable bowelsyndrome in workingadults. J Psychosom Res. 2020;134:110121-.
26. Patacchioli FR, Angelucci L, Dell'Erba G, Monnazzi P, Leri O. Actual stress, psychopathology and salivary cortisol levels in the irritable bowelsyndrome (IBS). J Endocrinol Invest. 2001;24(3):173–7.
27. Jahrami H, Sater M, Abdulla A, FarisMeA-I, AlAnsari A. Eatingdisordersriskamong medical students: a global systematicreview and meta-analysis. Eat Weight Disord. 2019;24(3):397–410.
28. Hodkinson A, Zhou A, Johnson J, Geraghty K, Riley R, Zhou A, et al. Associations of physician burnout with career engagement and quality of patient care: systematic review and meta-analysis. BMJ. 2022;378:e070442.
29. Goyal O, Nohria S, Dhaliwal AS, Goyal P, Soni RK, Chhina RS, et al. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India. Indian J Gastroenterol. 2021;40(2):144–53.
30. Bogowicz P, Ferguson J, Gilvarry E, Kamali F, Kaner E, Newbury-Birch D. Alcohol and other substance use among medical and law students at a UK university: a cross-sectional questionnaire survey. Postgrad Med J. 2018;94(1109):131–6.
Lydia C. Brown, 1 Third-year Medical Student. University of Sheffield, United Kingdom
Imran Aziz, 2 Academic Unit of Gastroenterology, Sheffield Teaching Hospitals & University of Sheffield, United Kingdom.
About the Author: Lydia Brown has undertaken a BMedSci research degree at the University of Sheffield. This body of work has been presented as a poster abstract at the British Society of Gastroenterology and the United European Gastroenterology Week in 2023.
Correspondence: Imran Aziz. Address: Sheffield S10 2TN, UK. Email: imran.aziz1@nhs.net
Editor: Francisco J. Bonilla-Escobar; Student Editors:Hang-Long (Ron) Li & Carlos de la Cruz-de la Cruz; Proof reader: Laeeqa Manji; Layout Editor: Julián A. Zapata Ríos; Process: Peer-reviewed
Prevalence of Disorders of Gut Brain Interaction (DGBI) in Medical Students from Across the Globe.
Authors | Country | Year of study | Number of participants | Criteria | Prevalence |
---|---|---|---|---|---|
Any DGBI | |||||
Gallas et al. | Tunisia | 2022 | 343 | Rome III | 54.2% |
Goyal et al. | India | 2021 | 425 | Rome IV | 34.4% |
Any functional bowel disorder | |||||
Chu et al. | China | 2012 | 1071 | Rome III | 68.5% |
Irritable Bowel Syndrome (IBS) | |||||
Tan et al. | Malaysia | 2003 | 533 | Rome I | 15.8% |
Jafri et al. | Pakistan | 2005 | 245 | Rome II | 26.0% |
Okeke et al. | Nigeria | 2005 | 330 | Rome II | 26.1% |
Shen et al. | China | 2009 | 313 | Rome II | 13.4% |
Mansour-Ghanaeiet al. | Iran | 2009 | 422 | Rome II | 12.6% |
Okami et al. | Japan | 2011 | 1768 | Rome II | 35.5% |
Dong et al. | China | 2010 | 728 | Rome III | 9.3% |
Jung et al. | Korea | 2011 | 319 | Rome III | 29.2% |
Wells et al. | Canada | 2012 | 228 | Rome III | 20.6% |
Naeem et al. | Pakistan | 2012 | 360 | Rome III | 28.3% |
Ibrahim et al. | Saudi Arabia | 2013 | 597 | Rome III | 29% |
Liu et al. | China | 2014 | 767 | Rome III | 33.2% |
Al Ghamdiet al. | Saudi Arabia | 2015 | 167 | Rome III | 21.0% |
Darweeshet al. | Egypt | 2015 | 86 | Rome III | 22.1% |
Costanianet al. | Lebanon | 2015 | 431 | Rome III | 20.6% |
Wang et al. | China | 2016 | 1874 | Rome III | 31.9% |
Perveenet al. | Bangladesh | 2016 | 293 | Rome III | 4.8% |
Husain et al. | Romania | 2016 | 102 | Rome III | 24.5% |
Alaqueelet al. | Saudi Arabia | 2017 | 270 | Rome III | 21.1% |
Pozos-Radilloet al. | Mexico | 2018 | 561 | Rome III | 61.7% |
Elhosseinyet al. | Egypt | 2019 | 382 | Rome III | 31.7% |
Shafique et al. | Pakistan | 2021 | 370 | Rome III | 41.1% |
Javedet al. | Pakistan | 2022 | 305 | Rome III | 5.57% |
Gallaset al. | Tunisia | 2022 | 3431 | Rome III | 7.6% |
El Sharawyet al. | Egypt | 2022 | 182 | Rome III | 27.5% |
Jadallahet al. | Jordan | 2022 | 1094 | Rome III | 30.9% |
Jia et al. | China | 2022 | 2739 | Rome III | 12.23% |
Goyal et al. | India | 2021 | 1309 | Rome III | 9.5% |
Rome IV | 6.2% | ||||
Hasosahet al. | Saudi Arabia | 2017 | 179 | Rome IV | 13.2% |
Sehonou and Dodo | Benin | 2018 | 315 | Rome IV | 14% |
Alshammariet al. | Saudi Arabia | 2018 | 133 | Rome IV | 28.6% |
Hakamiet al. | Saudi Arabia | 2019 | 252 | Rome IV | 7.9% |
AlButayshet al. | Saudi Arabia | 2020 | 232 | Rome IV | 31.9% |
Anthea et al. | Malta | 2021 | 135 | Rome IV | 17.8% |
Alreshidiet al. | Saudi Arabia | 2022 | 301 | Rome IV | 20.9% |
Gravinaet al. | Italy | 2023 | 161 | Rome IV | 21.1% |
Tran et al. | Vietnam | 2023 | 400 | Rome IV | 5.5% |
Wani et al. | Saudi Arabi | 2020 | 90 | Unknown | 42.2% |
Functional Dyspepsia (FD) | |||||
Basandra and Divyansh | India | 2014 | 200 | Rome III | 18% |
Shankar et al. | Pakistan | 2020 | 221 | Rome III | 34.8% |
Gallaset al. | Tunisia | 2022 | 242 | Rome III | 6.7% |
Javedet al. | Pakistan | 2022 | 305 | Rome III | 0.66% |
Goyal et al. | India | 2021 | 1309 | Rome IV | 15.2% |
Looret al. | Romania | 2021 | 150 | Rome IV | 18% |
Tran et al. | Vietnam | 2023 | 400 | Rome IV | 6.5% |
1.
Gallas S, Knaz H, Methnani J, et al. Prevalence and risk factors of functional gastrointestinal disorders in early period
medical students: a pilot study in Tunisia. Libyan J Med. 2022;17(1) doi: http://dx.doi.org/10.1080/19932820.2022.2082029
2.
Goyal O, Nohria S, Dhaliwal AS, et al. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders
among college students in northern India. Indian J Gastroenterol. 2021;40(2):144–153. doi: http://dx.doi.org/10.1007/s12664-020-01106-y
3. Chu L, Zhou H, Lü B, Li M, Chen M-y. [An epidemiological study of functional bowel disorders in Zhejiang college students and its relationship with psychological factors]. ZhonghuaNeiKe Za Zhi. 2012/06// 2012;51(6):429–432.
4.
Tan Y-M, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: A survey among medical
students. Journal of Gastroenterology and Hepatology. 2003;18(12):1412–1416. doi: http://dx.doi.org/10.1046/j.1440-1746.2003.03212.x
5. Jafri W, Yakoob J, Jafri N, Islam M, Ali QM. Frequency of irritable bowel syndrome in college students. Journal of Ayub Medical College Abbottabad. 2005;17(4):9.
6. Okeke EN, Agaba EI, Gwamzhi L, Achinge GI, Angbazo D, Malu AO. Prevalence of irritable bowel syndrome in a Nigerian student population. Afr J Med Med Sci. 2005/03// 2005;34(1):33–36.
7.
Shen L, Kong H, Hou X. Prevalence of irritable bowel syndrome and its relationship with psychological stress
status in Chinese university students. http://dx.doi.org/10.1111/j.1440-1746.2009.05943.x. Journal of Gastroenterology and Hepatology. 2009/12/01 2009;24(12):1885–1890. doi: http://dx.doi.org/10.1111/j.1440-1746.2009.05943.x
8. Mansour-Ghanaei F, Fallah M, Heidarzadeh A, et al. Prevalence and characteristics of irritable bowel syndrome (IBS) amongst medical students of Gilan Northern Province of Iran. Middle East Journal of Digestive Diseases (MEJDD). 2009;1(2):100–105.
9.
Okami Y, Kato T, Nin G, et al. Lifestyle and psychological factors related to irritable bowel syndrome in nursing
and medical school students. Journal of Gastroenterology. 2011;46(12):1403–1410. doi: http://dx.doi.org/10.1007/s00535-011-0454-2
10.
Dong Y-Y. Prevalence of irritable bowel syndrome in Chinese college and university students
assessed using Rome III criteria. World Journal of Gastroenterology. 2010;16(33):4221. doi: http://dx.doi.org/10.3748/wjg.v16.i33.4221
11.
Jung HJ, Park MI, Moon W, et al. Are Food Constituents Relevant to the Irritable Bowel Syndrome in Young Adults? -
A Rome III Based Prevalence Study of the Korean Medical Students. Journal of Neurogastroenterology and Motility. 2011;17(3):294–299. doi: http://dx.doi.org/10.5056/jnm.2011.17.3.294
12.
Wells M, Roth L, McWilliam M, Thompson K, Chande N. A Cross-Sectional Study of the Association between Overnight Call and Irritable Bowel
Syndrome in Medical Students. Canadian Journal of Gastroenterology. 2012;26(5):281–284. doi: http://dx.doi.org/10.1155/2012/865915
13.
Naeem SS, Siddiqui EU, Kazi AN, Memon AA, Khan ST, Ahmed B. Prevalence and factors associated with irritable bowel syndrome among medical students
of Karachi, Pakistan: A cross-sectional study. BMC Research Notes. 2012;5(1):255. doi: http://dx.doi.org/10.1186/1756-0500-5-255
14.
Ibrahim NKR, Battarjee WF, Almehmadi SA. Prevalence and predictors of irritable bowel syndrome among medical students and interns
in King Abdulaziz University, Jeddah. Libyan Journal of Medicine. 2013;8(1):21287. doi: http://dx.doi.org/10.3402/ljm.v8i0.21287
15.
Liu Y, Liu L, Yang Y, et al. A School-Based Study of Irritable Bowel Syndrome in Medical Students in Beijing, China:
Prevalence and Some Related Factors. Gastroenterology Research and Practice. 2014;2014:1–8. doi: http://dx.doi.org/10.1155/2014/124261
16. Al Ghamdi S, AlOsamey F, AlHamdan A, et al. A study of impact and prevalence of irritable bowel syndrome among medical students. International Journal of Medicine and Medical Sciences. 2015;7(9):139–147.
17. Darweesh MM, Abd El Hameed MAM, Hassan YM, et al. The prevalence of irritable bowel syndrome among medical and non-medical Suez Canal University students. Open Journal of Gastroenterology. 2015;5(05):42.
18.
Costanian C. Prevalence and factors associated with irritable bowel syndrome among university students
in Lebanon: Findings from a cross-sectional study. World Journal of Gastroenterology. 2015;21(12):3628. doi: http://dx.doi.org/10.3748/wjg.v21.i12.3628
19. Wang Y, Jin F, Chi B, et al. Gender differences in irritable bowel syndrome among medical students at Inner Mongolia Medical University, China: a cross-sectional study. Psychology, health & medicine. 2016;21(8):964–974.
20. Perveen I, Parvin R, Saha M, Bari MS, Huda MN, Ghosh MK. Prevalence of irritable bowel syndrome (IBS), migraine and co-existing IBS-migraine in medical students. Journal of Clinical and Diagnostic Research: JCDR. 2016;10(11):OC09.
21. Husain M, Dumitrascu D, Chaudhry I. Irritable bowel syndrome (IBS) and stress; a study of international medical school students. European Psychiatry. 2016;33(S1):S633–S633.
22.
Alaqeel MK, Alowaimer NA, Alonezan AF, Almegbel NY, Alaujan FY. Prevalence of irritable bowel syndrome and its association with anxiety among medical
students at King Saud bin Abdulaziz University for health sciences in Riyadh. Pak J Med Sci. 2017;33(1):33–36. doi: http://dx.doi.org/10.12669/pjms.331.12572
23. Pozos-Radillo E, Preciado-Serrano L, Plascencia-Campos A, Morales-Fernández A, Valdez-López R. Predictive study of academic stress with the irritable bowel syndrome in medicine students at a public university in Mexico. Libyan Journal of Medicine. 2018;13(1)
24.
Elhosseiny D, Mahmoud NE, Manzour AF. Factors associated with irritable bowel syndrome among medical students in Ain Shams
University. Journal of the Egyptian Public Health Association. 2019;94(1):1–9. doi: http://dx.doi.org/10.1186/s42506-019-0023-8
25.
Shafique S, Faraz N, Wasti H, Surti A. Irritable bowel syndrome among medical students and its association with anxiety. The Professional Medical Journal. 2021;28(11):1561–1565. doi: http://dx.doi.org/10.29309/tpmj/2021
26.
Javed M, Yadav T, Shakil J, Haider Zaidi ST, Zehra M. Prevalence of irritable bowel syndrome and functional dyspepsia and their relationship
with generalized anxiety disorder among medical students in Karachi. J Pak Med Assoc. 2022;72(10):2132–2136. doi: http://dx.doi.org/10.47391/JPMA.4927
27.
El Sharawy SM, Amer IF, Elkadeem MZ. Irritable bowel syndrome in Egyptian medical students, prevalence and associated factors:
a cross-sectional study. The Pan African medical journal. 2022;41:311–311. doi: http://dx.doi.org/10.11604/pamj.2022.41.311.28228
28.
Jadallah KA, Khatatbeh MM, Sarsak EW, Sweidan AN, Alzubi BF. Irritable bowel syndrome and its associated factors among Jordanian medical students:
A cross-sectional study. Medicine (Baltimore). 2022;101(33):e30134–e30134. doi: http://dx.doi.org/10.1097/MD.0000000000030134
29.
Jia W, Liang H, Wang L, et al. Associations between Abnormal Eating Styles and Irritable Bowel Syndrome: A Cross-Sectional
Study among Medical School Students. Nutrients. 2022;14(14):2828. doi: http://dx.doi.org/10.3390/nu14142828
30. Hasosah MY, Alamri SA, Al-Husayni FA, Aljedaani RM, Zwawy MA, Al-Zahrani AA. Prevalence of Irritable Bowel Syndrome among Medical Students and Interns in Jeddah, Saudi Arabia. J Clin Med Case Stud| Volume. 2017;2(4)
31. Sehonou J, Dodo LRS. Profilclinique et facteursassociés au syndrome de l'intestin irritable chez les étudiantsenmédecine à Cotonou, Bénin. Pan African Medical Journal. 2018;31(1)
32. Alshammari OM, Almuslam AS, Alrashidi AA, et al. Prevalence of Irritable Bowel Syndrome among Medical Students in Hail University, Saudi Arabia. The Egyptian Journal of Hospital Medicine. 2018;71(2):2581–2584.
33.
Hakami RM, Elmakki E, Hasanain T, et al. Irritable Bowel Syndrome: assessment of prevalence and risk factors in Saudi University
students using Rome IV Criteria. Gastroenterology Insights. 2019;10(1)doi: http://dx.doi.org/10.4081/gi.2019.8239
34.
AlButaysh O, AlQuraini A, Almukhaitah A, Alahmdi Y, Alharbi F. Epidemiology of irritable bowel syndrome and its associated factors in Saudi undergraduate
students. Saudi J Gastroenterol. 2020;26(2):89–93. doi: http://dx.doi.org/10.4103/sjg.SJG_459_19
35. Anthea P, Tiziana F, Francesca P, Pierre E. Prevalence, behaviours and burden of irritable bowel syndrome in medical students and junior doctors. The Ulster Medical Journal. 2021;90(1):16.
36.
Alreshidi FF, Alsammari MA, Almallahi AE, et al. Prevalence of Irritable Bowel Syndrome IBS and Its Risk Factors among Medical Students
in Hail University. International Journal of Pharmaceutical Research and Allied Sciences. 2022;11(2):45–51. doi: http://dx.doi.org/10.51847/VDfCLB5GFG
37. Gravina G, Pellegrino R, Romeo M, et al. The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey. Reviews on Recent Clinical Trials. 2023;
38.
Tran TTT, Luu MN, Tran LL, Nguyen D, Quach DT, Hiyama T. Association of mental health conditions and functional gastrointestinal disorders
among Vietnamese new-entry medical students. PLOS ONE. 2023;18(7):e0289123. doi: http://dx.doi.org/10.1371/journal.pone.0289123
39. Wani F, Almaeen A, Bandy A, et al. Prevalence and risk factors of IBS among medical and nonmedical students in the Jouf University. Nigerian Journal of Clinical Practice. 2020;23(4):555–560.
40.
Basandra S, Divyansh D. Epidemiology of dyspepsia and irritable bowel syndrome (IBS) in medical students of
Northern India. J Clin Diagn Res. 2014;8(12):JC13–JC16. doi: http://dx.doi.org/10.7860/JCDR/2014/10710.5318
41.
Shankar P, Mandhan N, Hussain Zaidi SM, Choudhry MS, Kumar A. Relationship of functional dyspepsia with mental and physical stress. Annals of Psychophysiology. 2020;7(1):25–30. doi: http://dx.doi.org/10.29052/2412-3188.v7.i1.2020.25-30
42.
Loor A, Dumitrascu D-L, Surdea-Blaga T, Leucuta D-C, David L. Helicobacter pylori infection and positive Rome IV criteria for functional dyspepsia
in Romanian medical students. Journal of medicine and life. 2021;14(4):492–497. doi: http://dx.doi.org/10.25122/jml-2021-0163
Copyright © 2024 Lydia C. Brown, Imran Aziz
This work is licensed under a Creative Commons Attribution 4.0 International License.
International Journal of Medical Students, VOLUME 12, NUMBER 1, March 2024